Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline plus Antimony in Cutaneous Leishmaniasis
NCT01381055Phase 3Completed
- Start
- Mar 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pentoxifylline in cutaneous leishmaniasis (CL). Started Mar 2012; status: completed.
02
Drugs
pentoxifylline
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT01381055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01381055.